- Round ID
- FR-00135
- Stage
- Series D
- Round name
- Series D (2021) + follow-on round (2023, stage/series label unclear)
- Amount
- $600m (2021 Series D); $165m (2023 follow-on, existing investors only)
Dated funding evidence
CMR Surgical
Series D · $600m (2021 Series D); $165m (2023 follow-on, existing investors only) · 2023-10-01
Reported round$600m (2021 Series D); $165m (2023 follow-on, existing investors only)Series D
- Disclosure date
- 2023-10-01
- Reported currency
- USD
- Companies House
- 08863657
- Evidence sources
- 2
Company
CMR SurgicalCH 088636572023-10-01Series D$600m (2021 Series D); $165m (2023 follow-on, existing investors only)
Resolved investor records
SoftBank Vision Fund 2Lead investorAlly Bridge GroupInvestorCambridge Innovation CapitalInvestorEscala CapitalInvestorLGTInvestorLightrockInvestorRPMI RailpenInvestorTencentInvestorWatriumInvestor
Investor links inherit this round’s named source and date. Resolved links use an exact canonical investor name; unresolved names remain unlinked.
Record fields
What the source states
Amounts, currency, stage and investor names are preserved as reported. No FX conversion, valuation inference or current-holding claim is added.
- Lead investors
- SoftBank Vision Fund 2
- Other investors
- Ally Bridge Group, Cambridge Innovation Capital, Escala Capital, LGT, Lightrock, RPMI Railpen, Tencent, Watrium
- Source layers
- VC research snapshot, Live Chris T D1
- Snapshot
- 2026-08-15
Named evidence
Source trail
This page is published only when the record has a resolved company, disclosure date, round stage and at least one retained source URL.